Neuroscience Translational Medicine, Novartis Institutes for Biomedical Research, Novartis Pharma AG, CH-4056 Basel, Switzerland.
Sci Transl Med. 2012 Apr 25;4(131):131fs9. doi: 10.1126/scitranslmed.3004017.
Paving the way for clinical trials, a new study shows that a glutamate receptor antagonist reduces repetitive behavior and social deficits in a mouse model of autism spectrum disorder.
为临床试验铺平道路,一项新的研究表明,一种谷氨酸受体拮抗剂可减少自闭症谱系障碍小鼠模型的重复行为和社交缺陷。